《Table 1.Clinical Characteristics of CKD Participants[Median (IQR) ]》

  提示：宽带有限、当前游客访问压缩模式

本系列图表出处文件名：随高清版一同展现

《"Effects of Niaoduqing Particles(尿毒清颗粒)on Delaying Progression of Renal Dysfunction:A Post-trial,Open-Label,Follow-up Study"》

1. 获取 高清版本忘记账户？点击这里登录

1. 下载图表忘记账户？点击这里登录

Notes:IQR:interquartile range；eGFR:estimated glomerular filtration rate；Scr:serum creatinine；SBP:systolic blood pressure；DBP:diastolic blood pressure；UPE:urinary protein excretion

The patient enrollment protocol for the doubleblind trial period was published previously.（15）As shown in Figure 1，146 participants in each group entered the full analysis set（FAS）.The characteristics of the entire trial cohort at baseline，post-doubleblind period and post-open-label period are shown according to the original study-group assignments，and there were no significant differences at the three periods between Niaoduqing and placebo groups（age:50.8±11.7 vs.50.7±11.9 years；male proportion:56.9%vs.56.2%，P>0.05，Table 1）.